Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-54452840 in Heart Failure with Anti-Beta 1 Autoantibodies
NCT01798745Phase 2Withdrawn
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2014
- Primary completion
- Dec 2015
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Peptides
01
Overview
A Phase 2 trial of Mibenratide in heart failure (HF), sponsored by Janssen Pharmaceutical. Planned start Nov 2014; status: withdrawn.
02
Drugs
Mibenratide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01798745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01798745.